Stock HIMS HIMS & HERS HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
12.5 USD +1.87% Intraday chart for Hims & Hers Health, Inc. +5.04% +40.45%
Apr. 26 Seaport Global Starts Hims & Hers Health With Buy Rating MT
Apr. 16 Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company does not generate enough profits, which is an alarming weak point.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 161.32 times its estimated earnings per share for the ongoing year.
  • The company appears highly valued given the size of its balance sheet.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
HIMS & HERS HEALTH, INC. Stock Hims & Hers Health, Inc.
+40.45% 2.63B -
TALKSPACE, INC. Stock Talkspace, Inc.
+22.83% 520M -
QDM INTERNATIONAL INC. Stock QDM International Inc.
+42.77% 467M - -
AMERICAN WELL CORPORATION Stock American Well Corporation
-64.56% 160M
C-
SHL TELEMEDICINE LTD. Stock SHL Telemedicine Ltd.
-31.65% 87.05M -
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HIMS Stock
  4. Ratings Hims & Hers Health, Inc.